Nanomedicine
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.6 | Q2 | 70.6% | 0.681 | Q1 | 72.0% |
| 2024 | 3.9 | Q2 | 70.1% | 0.572 | Q2 | 66.8% |
| 2023 | 4.7 | Q2 | 57.6% | 0.670 | Q1 | 74.4% |
| 2022 | 5.5 | Q1 | 59.3% | 0.695 | Q1 | 76.7% |
| 2021 | 6.1 | Q3 | 64.6% | 0.803 | Q1 | 81.2% |
| 2020 | — | — | 0.947 | Q1 | 84.1% | |
| 2019 | — | — | 0.997 | Q1 | 85.5% | |
| 2018 | — | — | 1.069 | Q1 | 85.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1743-5889
ISSN
1748-6963
region
Western Europe
coverage
2006-2026